Open access · CC-BY
via OpenAlex
AZT as a telomerase inhibitor
Daniel Eduardo Gomez, Romina Gabriela Armando, Daniel F. Alonso
Frontiers in Oncology · 2012 · ▲ 61 citations
Abstract
Telomerase is a highly specialized reverse transcriptase (RT) and the maintenance of telomeric length is determined by this specific enzyme. The human holoenzyme telomerase is a ribonucleoprotein composed by a catalytic subunit, hTERT, an RNA component, hTR, and a group of associated proteins. Telomerase is normally expressed in embryonic cells and is repressed during adulthood. The enzyme is reexpressed in around 85% of solid tumors. This observation makes it a potential target for developing drugs that could be developed for therapeutic purposes. The identification of the hTERT as a functional catalytic RT prompted studies of inhibiting telomerase with the HIV RT inhibitor azidothymidine (AZT). Previously, we have demonstrated that AZT binds preferentially to telomeres, inhibits telomerase and enhances tumor cell senescence(definition), and apoptosis after AZT treatment in breast mammary adenocarcinoma cells. Since then, several studies have considered AZT for telomerase inhibition and have led to potential clinical strategies for anticancer therapy. This review covers present thinking of the inhibition of telomerase by AZT and future treatment protocols using the drug.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fonc.2012.00113
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Gomez, D.E., Armando, R.G., & Alonso, D.F. (2012). AZT as a telomerase inhibitor. <em>Frontiers in Oncology</em>. https://doi.org/10.3389/fonc.2012.00113
Vancouver
Gomez DE, Armando RG, Alonso DF. AZT as a telomerase inhibitor. Frontiers in Oncology. 2012. doi:10.3389/fonc.2012.00113.
BibTeX
@article{daniel2012AZTasa,
title = {AZT as a telomerase inhibitor},
author = {Daniel Eduardo Gomez and Romina Gabriela Armando and Daniel F. Alonso},
journal = {Frontiers in Oncology},
year = {2012},
doi = {10.3389/fonc.2012.00113},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Genes & Development 1998
Preprint · OA
Myc activates telomerase
British Journal of Pharmacology 2007
Open access · OA
Telomerase and its potential for therapeutic intervention
Medicinal Research Reviews 2020
Preprint · OA
Targeting telomerase for its advent in cancer therapeutics
Fertility and Sterility 2014
Open access · OA
Enhancement of telomere maintenance using telomerase activation in human cells
Genes & Development 1999
Preprint · OA
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
Science-Business eXchange 2008
Open access · OA